Harbour Antibodies Licenses H2L2 Mice to Pfizer MarketWatch ROTTERDAM, the Netherlands & CAMBRIDGE, Mass., Jul 24, 2013 (BUSINESS WIRE) -- Harbour Antibodies, the creator of transgenic mice to aid in the development of new human therapeutic antibodies, announced today that it has licensed its H2L2 mice, ... Harbour Antibodies BV Raises ‚Ǩ2.5M ($3.3M) to Accelerate the Development ... Atlas leads €2.5m round for Harbour Antibodies Pfizer licenses antibody tech from Atlas-backed startup Harbour |
